Carotid Baroreceptor Stimulation Ameliorates Pulmonary Arterial Remodeling in Rats With Hypoxia-Induced Pulmonary Hypertension

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 30

PMID 39344593

Authors

Xuesheng Fang

Jie Chen

Zhiling Hu

Ling Shu

Jing Wang

Mingyan Dai

Tuantuan Tan

Junxia Zhang

Mingwei Bao

Affiliations

Soon will be listed here.

Abstract

Background: Sympathetic hyperactivity plays an important role in the initiation and maintenance of pulmonary hypertension. Carotid baroreceptor stimulation (CBS) is an effective autonomic neuromodulation therapy. We aim to investigate the effects of CBS on hypoxia-induced pulmonary hypertension and its underlying mechanisms.

Methods And Results: Rats were randomly assigned into 4 groups, including a Control-sham group (n=7), a Control-CBS group (n=7), a Hypoxia-sham group (n=10) and a Hypoxia-CBS group (n=10). Echocardiography, ECG, and hemodynamics examination were performed. Samples of blood, lung tissue, pulmonary arteries, and right ventricle were collected for the further analysis. In the in vivo study, CBS reduced wall thickness and muscularization degree in pulmonary arterioles, thereby improving pulmonary hemodynamics. Right ventricle hypertrophy, fibrosis and dysfunction were all improved. CBS rebalanced autonomic tone and reduced the density of sympathetic nerves around pulmonary artery trunks and bifurcations. RNA-seq analysis identified and periostin () as key genes involved in hypoxia-induced pulmonary hypertension, and CBS downregulated the mRNA expression of and in rat pulmonary arteries. In the in vitro study, norepinephrine was found to promote pulmonary artery smooth muscle cell proliferation while upregulating and expression. The proliferative effect was alleviated by silence or .

Conclusions: Our results showed that CBS could rebalance autonomic tone, inhibit pulmonary arterial remodeling, and improve pulmonary hemodynamics and right ventricle function, thus delaying hypoxia-induced pulmonary hypertension progression. There may be a reciprocal interaction between and that is responsible for the underlying mechanism.

References

Kovacs L, Cao Y, Han W, Meadows L, Kovacs-Kasa A, Kondrikov D . PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2019; 200(5):617-627. PMC: 6727156. DOI: 10.1164/rccm.201812-2290OC. View

de Man F, Handoko M, van Ballegoij J, Schalij I, Bogaards S, Postmus P . Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail. 2011; 5(1):97-105. DOI: 10.1161/CIRCHEARTFAILURE.111.964494. View

Dignam J, Scott T, Kemp-Harper B, Hobbs A . Animal models of pulmonary hypertension: Getting to the heart of the problem. Br J Pharmacol. 2021; 179(5):811-837. DOI: 10.1111/bph.15444. View

Luo Q, Wang X, Liu R, Qiao H, Wang P, Jiang C . alpha1A-adrenoceptor is involved in norepinephrine-induced proliferation of pulmonary artery smooth muscle cells via CaMKII signaling. J Cell Biochem. 2018; 120(6):9345-9355. DOI: 10.1002/jcb.28210. View

Na S, Kim O, Ryoo S, Kweon T, Choi Y, Shim H . Cervical ganglion block attenuates the progression of pulmonary hypertension via nitric oxide and arginase pathways. Hypertension. 2013; 63(2):309-15. DOI: 10.1161/HYPERTENSIONAHA.113.01979. View

Zhao Y, Xiang R, Peng X, Dong Q, Li D, Yu G . Transection of the cervical sympathetic trunk inhibits the progression of pulmonary arterial hypertension via ERK-1/2 Signalling. Respir Res. 2019; 20(1):121. PMC: 6567667. DOI: 10.1186/s12931-019-1090-2. View

Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C . Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension. Circulation. 2018; 139(7):932-948. DOI: 10.1161/CIRCULATIONAHA.118.033744. View

Aldred M, Morrell N, Guignabert C . New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis. Circ Res. 2022; 130(9):1365-1381. PMC: 9897592. DOI: 10.1161/CIRCRESAHA.122.320084. View

Wang J, Yu Q, Dai M, Zhang Y, Cao Q, Luo Q . Carotid baroreceptor stimulation improves cardiac performance and reverses ventricular remodelling in canines with pacing-induced heart failure. Life Sci. 2019; 222:13-21. DOI: 10.1016/j.lfs.2019.02.047. View

10.

Kim L, Polotsky V . Carotid Body and Metabolic Syndrome: Mechanisms and Potential Therapeutic Targets. Int J Mol Sci. 2020; 21(14). PMC: 7404212. DOI: 10.3390/ijms21145117. View

11.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

12.

Ciarka A, Doan V, Velez-Roa S, Naeije R, van de Borne P . Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010; 181(11):1269-75. DOI: 10.1164/rccm.200912-1856OC. View

13.

Ye C, Zheng F, Xu T, Wu N, Tong Y, Xiong X . Norepinephrine acting on adventitial fibroblasts stimulates vascular smooth muscle cell proliferation via promoting small extracellular vesicle release. Theranostics. 2022; 12(10):4718-4733. PMC: 9254254. DOI: 10.7150/thno.70974. View

14.

Zhang Z, Nie F, Kang C, Chen B, Qin Z, Ma J . Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions. Int J Mol Med. 2014; 34(1):253-61. DOI: 10.3892/ijmm.2014.1760. View

15.

Thompson A, Lawrie A . Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension. Trends Mol Med. 2016; 23(1):31-45. DOI: 10.1016/j.molmed.2016.11.005. View

16.

Velez-Roa S, Ciarka A, Najem B, Vachiery J, Naeije R, van de Borne P . Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004; 110(10):1308-12. DOI: 10.1161/01.CIR.0000140724.90898.D3. View

17.

Wang L, Moonen J, Cao A, Isobe S, Li C, Tojais N . Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension. Circ Res. 2023; 132(5):545-564. PMC: 10008520. DOI: 10.1161/CIRCRESAHA.121.320541. View

18.

Hartman W, Helan M, Smelter D, Sathish V, Thompson M, Pabelick C . Role of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth Muscle. PLoS One. 2015; 10(7):e0129489. PMC: 4507987. DOI: 10.1371/journal.pone.0129489. View

19.

Liu R, Zhang Q, Luo Q, Qiao H, Wang P, Yu J . Norepinephrine stimulation of alpha1D-adrenoceptor promotes proliferation of pulmonary artery smooth muscle cells via ERK-1/2 signaling. Int J Biochem Cell Biol. 2017; 88:100-112. DOI: 10.1016/j.biocel.2017.05.001. View

20.

Xiao X, Zhang Y, Tian S, Wang X, Zhang Q, Zhang L . Alpha1B-adreneroceptor is involved in norepinephrine-induced pulmonary artery smooth muscle cell proliferation via p38 signaling. Eur J Pharmacol. 2022; 931:175159. DOI: 10.1016/j.ejphar.2022.175159. View